PRQR - ProQR Therapeutics

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• ProQR GAAP EPS of -€0.07, revenue of €1.37M
• ProQR GAAP EPS of -€0.10, revenue of €1.21M
• ProQR gains on deal to divest eye disease therapies
• ProQR GAAP EPS of -€0.11, revenue of €0.66M
• Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB (updated)
• ProQR adds 75% as Cantor upgrades on expanded deal with Eli Lilly
• Eli Lilly sends ProQR 35% higher after expanding RNA editing deal
• ProQR GAAP EPS of -€0.34, revenue of €0.96M
• AstraZeneca – LogicBio deal indicates more such takeovers are ahead – Cantor
• ProQR upgraded at Raymond James on RNA-editing platform
• ProQR says EU regulator seeks additional trial for lead candidate
• ProQR GAAP EPS of -$0.21 beats by €0.02, revenue of €1.02M beats by €0.07M
• ProQR GAAP EPS of -€0.20, revenue of €1.23M
• ProQR GAAP EPS of -€0.26, revenue of €0.24M
• ProQR cut to Neutral at Citi after “puzzling” trial results for RNA therapy
• ProQR says trial for sepofarsen in Leber congenital amaurosis did not meet main goal
• Catalyst Watch for next week: Eyes on Uber, Hertz, Amgen, Peloton and AMD
• ProQR Therapeutics expects phase 2/3 trial data of eye disorder RNA therapy in Q1
• ProQR amends convertible debt financing agreement with Pontifax Ventures and Kreos Capital
• Dosing underway in ProQR Therapeutics' late-stage QR-421a trial for retinitis pigmentosa

Date		Price		Open	High	Low		Vol	Change	ER
Mar 4		0.927		1.000	1.000	0.920		654.03K	-7.3%
Mar 3		1.000		1.030	1.050	0.985		893.53K	-1.96%
Mar 2		1.020		1.020	1.050	0.992		1.33M	0%
Mar 1		1.020		1.090	1.110	1.020		1.71M	-4.67%
Feb 28		1.070		1.050	1.110	1.020		1.65M	0.94%
Feb 25		1.060		1.060	1.100	1.050		1.19M	2.91%
Feb 24		1.030		0.975	1.070	0.951		2.10M	-3.74%
Feb 23		1.070		1.132	1.140	1.060		2.26M	-6.14%
Feb 22		1.140		1.170	1.200	1.100		2.76M	-6.56%
Feb 18		1.220		1.210	1.240	1.160		3.25M	1.67%
Feb 17		1.200		1.220	1.270	1.180		3.37M	-1.64%
Feb 16		1.220		1.250	1.250	1.180		3.90M	-3.17%
Feb 15		1.260		1.300	1.320	1.230		4.55M	0.80%
Feb 14		1.250		1.360	1.380	1.220		8.62M	-10.07%
Feb 11		1.390		1.680	1.680	1.330		35.54M	-75.35%
Feb 10		5.640		5.690	6.000	5.560		458.79K	-3.59%
Feb 9		5.850		5.890	5.970	5.670		532.34K	1.21%
Feb 8		5.780		6.030	6.150	5.460		933.00K	-2.69%
Feb 7		5.940		5.430	5.990	5.390		1.39M	9.59%
Feb 4		5.420		5.170	5.520	5.010		976.99K	5.04%